Evidence map›Paper›PMID 34708057›Full record

ArticleFrontiers in medicine2021

SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response.

Lisa Müller, Marcel Andrée, Philipp Niklas Ostermann, Nathalie Jazmati, Greta Flüh, Johannes C Fischer, Edwin Bölke, Eva Heger, Kanika Vanshylla, Florian Klein and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Lisa MüllerMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Marcel AndréeMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Philipp Niklas OstermannMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Nathalie JazmatiInstitute of Virology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Greta FlühInstitute of Virology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Johannes C FischerInstitute for Transplant Diagnostics and Cell Therapeutics, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Edwin BölkeDepartment of Radiation Oncology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany.
Eva HegerInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Kanika VanshyllaInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Florian KleinInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hilmar WisplinghoffInstitute of Virology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Heiner SchaalMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Ingo DrexlerMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Andreas WalkerMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Ortwin AdamsMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Jörg TimmMedical Faculty, Institute of Virology, Heinrich-Heine-University, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DEUniversity of Cologne · DEDüsseldorf University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prophylactic vaccination against SARS-CoV-2 is one of the most important measures to contain the COVID-19 pandemic. Recently, break-through infections following vaccination against this virus have been reported. Here, we describe the humoral immune response of break-through infections in fully vaccinated individuals of old age from an outbreak in a nursing home. In cooperation with the local health authority, blood samples from fully vaccinated and infected as well as fully vaccinated and uninfected residents of the nursing home were collected 4 weeks after the onset of the outbreak. The humoral immune response was determined in a neutralisation assay with replication-competent virus isolates and by a quantitative ELISA. In this outbreak a total of 23 residents and four health care workers were tested positive for SARS-CoV-2. Four residents were unvaccinated, including one with a severe course of disease who later severe disease course who later succumbed to infection. Despite their old age, all vaccinated residents showed no or only mild disease. Comparison of the humoral immune response revealed significantly higher antibody levels in fully vaccinated infected individuals compared to fully vaccinated uninfected individuals (

Indexed as

humoral immune responseinfectionneutralising antibodiesSARS-CoV-2sequencingvaccinationvariants

Identifiers

PMID34708057
PMCPMC8544807
OpenAlexW3206565726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.